Respiratory Syncytial Disease
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Safety and Immunogenicity Study to Evaluate Single- or Two-Dose Regimens Of RSV F Vaccine With and Without Aluminum Phosphate or Matrix-M1™ Adjuvants In Clinically-Stable Older Adults [Phase 2]
Phase 2 trial update evaluating single- or two-dose RSV F vaccine regimens with or without aluminum phosphate or Matrix-M1 adjuvants in clin…
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Phase 2a Respiratory Syncytial Virus (RSV) Human Challenge Study of Clesrovimab (MK-1654) in Healthy Participants (MK-1654-005) [Phase 2]
Phase 2a human challenge trial of MK-1654 (clesrovimab) in healthy participants has completed with results posted in 2021.